• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞因子在调节MCF-7细胞中17β-雌二醇羟基类固醇脱氢酶活性方面的相互作用。

The interaction of cytokines in regulating oestradiol 17 beta-hydroxysteroid dehydrogenase activity in MCF-7 cells.

作者信息

Duncan L J, Coldham N G, Reed M J

机构信息

Unit of Metabolic Medicine, St Mary's Hospital Medical School, Imperial College of Science, Technology and Medicine, London, England.

出版信息

J Steroid Biochem Mol Biol. 1994 May;49(1):63-8. doi: 10.1016/0960-0760(94)90301-8.

DOI:10.1016/0960-0760(94)90301-8
PMID:8003440
Abstract

Oestradiol 17 beta-hydroxysteroid dehydrogenase (E2DH) has a pivotal role in the regulation of oestradiol (E2) concentrations in normal and malignant breast tissues. Previous studies have suggested that a number of cytokines can stimulate E2DH activity to increase the conversion of oestrone (E1) to E2. In this investigation we have examined the effect of TNF alpha, interleukin-1 beta (IL-1 beta) and IL-6 on E2DH activity in MCF-7 breast cancer cells. These cytokines may be produced by breast tumours and their presence in conditioned medium (CM) from tumour-derived fibroblasts was also measured to assess their possible contribution to its E2DH stimulatory activity. Treatment of MCF-7 cells with IL-1 beta and TNF alpha (5 ng/ml) significantly increased (P < 0.001) reductive E2DH (red-E2DH, the conversion of E1 to E2) activity. In contrast, IL-6 at a concentration of 100 ng/ml produced little, if any, stimulation of reductive activity. Combinations of all three cytokines acted synergistically to stimulate red-E2DH activity. No cytokine, either alone or in combination, affected oxidative (E2-->E1) activity. Significant concentrations of IL-6 and IL-1 beta were detected in CM, but the stimulation of red-E2DH activity was much greater than that which could be explained by their levels alone. It is concluded that these cytokines may play an important role in regulating E2DH activity in breast cancer cells and may act synergistically in vivo to enhance the formation of E2 in breast tumours.

摘要

17β-羟基类固醇脱氢酶(E2DH)在正常和恶性乳腺组织中雌二醇(E2)浓度的调节中起关键作用。先前的研究表明,多种细胞因子可刺激E2DH活性,以增加雌酮(E1)向E2的转化。在本研究中,我们检测了肿瘤坏死因子α(TNFα)、白细胞介素-1β(IL-1β)和IL-6对MCF-7乳腺癌细胞中E2DH活性的影响。这些细胞因子可能由乳腺肿瘤产生,我们还检测了肿瘤来源的成纤维细胞条件培养基(CM)中它们的存在情况,以评估它们对E2DH刺激活性的可能贡献。用IL-1β和TNFα(5 ng/ml)处理MCF-7细胞可显著增加(P < 0.001)还原性E2DH(red-E2DH,E1向E2的转化)活性。相比之下,浓度为100 ng/ml的IL-6对还原性活性几乎没有刺激作用。三种细胞因子联合作用可协同刺激red-E2DH活性。单独或联合使用的任何细胞因子均不影响氧化(E2→E1)活性。在CM中检测到显著浓度的IL-6和IL-1β,但red-E2DH活性的刺激作用远大于仅由其水平所能解释的程度。结论是,这些细胞因子可能在调节乳腺癌细胞中E2DH活性方面起重要作用,并且可能在体内协同作用以增强乳腺肿瘤中E2的形成。

相似文献

1
The interaction of cytokines in regulating oestradiol 17 beta-hydroxysteroid dehydrogenase activity in MCF-7 cells.细胞因子在调节MCF-7细胞中17β-雌二醇羟基类固醇脱氢酶活性方面的相互作用。
J Steroid Biochem Mol Biol. 1994 May;49(1):63-8. doi: 10.1016/0960-0760(94)90301-8.
2
The effect of breast tumour and normal breast tissue cytosols on oestradiol 17 beta-hydroxysteroid dehydrogenase activity.乳腺肿瘤和正常乳腺组织胞质溶胶对雌二醇17β-羟基类固醇脱氢酶活性的影响。
Cancer Lett. 1989 Jan;44(1):45-8. doi: 10.1016/0304-3835(89)90106-7.
3
The role and proposed mechanism by which oestradiol 17 beta-hydroxysteroid dehydrogenase regulates breast tumour oestrogen concentrations.
J Steroid Biochem Mol Biol. 1995 Dec;55(5-6):565-72. doi: 10.1016/0960-0760(95)00207-3.
4
Effect of transforming growth factor-beta1, insulin-like growth factor-I and insulin-like growth factor-II on cell growth and oestrogen metabolism in human breast cancer cell lines.转化生长因子-β1、胰岛素样生长因子-I和胰岛素样生长因子-II对人乳腺癌细胞系细胞生长及雌激素代谢的影响
Pathology. 2001 Nov;33(4):454-9. doi: 10.1080/00313020120083179.
5
Regulation of oestradiol 17 beta hydroxysteroid dehydrogenase in breast tissues: the role of growth factors.乳腺组织中雌二醇17β-羟基类固醇脱氢酶的调节:生长因子的作用
J Steroid Biochem Mol Biol. 1991 Nov;39(5B):791-8. doi: 10.1016/0960-0760(91)90027-3.
6
Insulin-like growth factor type I and insulin-like growth factor type II stimulate oestradiol-17 beta hydroxysteroid dehydrogenase (reductive) activity in breast cancer cells.胰岛素样生长因子I型和胰岛素样生长因子II型刺激乳腺癌细胞中的雌二醇-17β羟类固醇脱氢酶(还原型)活性。
J Endocrinol. 1991 May;129(2):R5-8. doi: 10.1677/joe.0.129r005.
7
The effect of epidermal growth factor, transforming growth factor and breast tumour homogenates on the activity of oestradiol 17 beta hydroxysteroid dehydrogenase in cultured adipose tissue.表皮生长因子、转化生长因子及乳腺肿瘤匀浆对培养脂肪组织中雌二醇17β-羟类固醇脱氢酶活性的影响
Cancer Lett. 1986 May;31(2):213-9. doi: 10.1016/0304-3835(86)90013-3.
8
Effects of human breast fibroblasts on growth and 17 beta-estradiol dehydrogenase activity of MCF-7 cells in culture.人乳腺成纤维细胞对培养的MCF-7细胞生长及17β-雌二醇脱氢酶活性的影响。
Breast Cancer Res Treat. 1988 May;11(2):165-72. doi: 10.1007/BF01805840.
9
The role of cytokines and sulphatase inhibitors in regulating oestrogen synthesis in breast tumours.
J Steroid Biochem Mol Biol. 1995 Jun;53(1-6):413-20. doi: 10.1016/0960-0760(95)00087-g.
10
17 beta-estradiol dehydrogenase (E2DH) activity in T47D cells.T47D细胞中的17β-雌二醇脱氢酶(E2DH)活性。
J Steroid Biochem Mol Biol. 1991 Nov;39(5A):769-75. doi: 10.1016/0960-0760(91)90378-i.

引用本文的文献

1
The natural history of breast cancer: a chronological analysis of breast cancer progression using data from the SEER database.乳腺癌的自然史:利用监测、流行病学和最终结果(SEER)数据库的数据对乳腺癌进展进行的时间顺序分析。
Ann Transl Med. 2022 Mar;10(6):365. doi: 10.21037/atm-22-918.
2
Genetic and molecular biology of breast cancer among Iranian patients.伊朗患者乳腺癌的遗传和分子生物学。
J Transl Med. 2019 Jul 8;17(1):218. doi: 10.1186/s12967-019-1968-2.
3
Genetic variation in proinflammatory cytokines IL6, IL6R, TNF-region, and TNFRSF1A and risk of breast cancer.
促炎细胞因子 IL6、IL6R、TNF 区域和 TNFRSF1A 中的遗传变异与乳腺癌风险。
Breast Cancer Res Treat. 2011 Oct;129(3):887-99. doi: 10.1007/s10549-011-1520-4. Epub 2011 Apr 27.
4
Synergistic up-regulation of prostaglandin E synthase expression in breast cancer cells by 17beta-estradiol and proinflammatory cytokines.17β-雌二醇和促炎细胞因子对乳腺癌细胞中前列腺素E合酶表达的协同上调作用
Endocrinology. 2008 Dec;149(12):6272-9. doi: 10.1210/en.2008-0352. Epub 2008 Aug 14.
5
Genetic variation in tumor necrosis factor and lymphotoxin-alpha (TNF-LTA) and breast cancer risk.肿瘤坏死因子和淋巴毒素-α(TNF-LTA)的基因变异与乳腺癌风险
Hum Genet. 2007 May;121(3-4):483-90. doi: 10.1007/s00439-006-0315-x. Epub 2007 Jan 11.
6
Association of TNF-alpha and TNF-beta gene polymorphism with steroid receptor expression in breast cancer patients.肿瘤坏死因子-α和肿瘤坏死因子-β基因多态性与乳腺癌患者类固醇受体表达的关联
Pathol Oncol Res. 2005;11(2):99-102. doi: 10.1007/BF02893375. Epub 2005 Jul 1.
7
Estrogen metabolism as a regulator of estrogen action in the mammary gland.雌激素代谢作为乳腺中雌激素作用的调节因子。
J Mammary Gland Biol Neoplasia. 2000 Jul;5(3):259-70. doi: 10.1023/a:1009542710520.
8
Prognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patients.白细胞介素6血清水平以及血管内皮生长因子血清和血浆水平在激素难治性转移性乳腺癌患者中的预后价值
Br J Cancer. 2003 Jun 2;88(11):1721-6. doi: 10.1038/sj.bjc.6600956.
9
The role of cytokines in regulating estrogen synthesis: implications for the etiology of breast cancer.细胞因子在调节雌激素合成中的作用:对乳腺癌病因学的启示。
Breast Cancer Res. 2002;4(2):65-9. doi: 10.1186/bcr425. Epub 2002 Jan 14.
10
Direct activation of oestrogen receptor-alpha by interleukin-6 in primary cultures of breast cancer epithelial cells.白细胞介素-6在乳腺癌上皮细胞原代培养物中对雌激素受体α的直接激活作用。
Br J Cancer. 2000 Apr;82(7):1312-6. doi: 10.1054/bjoc.1999.1097.